Eslicarbazepine Acetate News
Eslicarbazepine Acetate currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Eslicarbazepine Acetate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Zebinix is indicated as adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.
- Evidence level: L5
- Predicted indications (20):
- partial epilepsy (99.0%)
- adolescent/adult onset autosomal dominant epilepsy with auditory features (98.7%)
- status epilepticus (98.7%)
- restless legs syndrome (98.5%)
- guanidinoacetate methyltransferase deficiency (98.5%)
- epilepsy with generalized tonic-clonic seizures (98.3%)
- visual epilepsy (98.3%)
- beta-ketothiolase deficiency (98.2%)
- eating seizures (97.5%)
- audiogenic seizures (97.5%)
- orgasm-induced seizures (97.5%)
- startle epilepsy (97.5%)
- thinking seizures (97.5%)
- micturation-induced seizures (97.5%)
- Rett syndrome, congenital variant (97.2%)
- 14q12 microdeletion syndrome (97.0%)
- reading seizures (96.9%)
- trigeminal nerve neoplasm (95.9%)
- partial motor epilepsy (95.3%)
- epilepsy (92.4%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.